 time prolongation bleeding infusion recombinant tissue-type plasminogen activator dogs potentiation aspirin reversal aprotinin Thrombolytic therapy bleeding tendency adjunctive antiplatelet agents effect recombinant tissue-type plasminogen activator rt-PA combination aspirin serial measurements template bleeding time platelet aggregation coagulation factors frequency bleeding dogs infusion rt-PA micrograms/kg min min dose-related increase time randomized study dogs baseline bleeding time mean SD min control animals min oral aspirin mg/kg body weight Infusion rt-PA micrograms/kg min min bleeding time maximum min contrast aspirin rt-PA therapy increase min infusion min cessation infusion Recurrent continuous incision sites dogs rt-PA dogs aspirin rt-PA time min bleeding frequency sensitivity specificity Intravenous bolus injection aprotinin kallikrein inhibitor units/kg body weight dogs rt-PA aspirin decrease time min min cessation bleeding time prolongation canine model marked interactive effect rt-PA aspirin reversible Template times useful quantitative index bleeding tendency thrombolytic therapy